ArticleOncotarget2017

A novel immunotherapy targeting MMP-14 limits hypoxia, immune suppression and metastasis in triple-negative breast cancer models.

Binbing Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.